Last reviewed · How we verify

NCT05544825

Ice Plant (Mesembryanthemum Crystallinum) Extract in Patients With Impaired Fasting Glucose

Completed NA Last updated 18 January 2024
What this trial tests

NA trial testing Ice plant group in Impaired Fasting Glucose in 40 participants. Completed in 31 October 2023.

Timeline
1 July 2022
Primary endpoint
30 October 2023
31 October 2023

Quick facts

Lead sponsorPusan National University Yangsan Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment40
Start date1 July 2022
Primary completion30 October 2023
Estimated completion31 October 2023
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Pusan National University Yangsan Hospital

Who can join

Adults 19 to 85, any sex, with Impaired Fasting Glucose. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators will conduct a randomized, double-blind, placebo-controlled study to investigate the effects and tolerability of ice plant (Mesembryanthemum crystallinum) extract in patients with impaired fasting glucose for 12 weeks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Pusan National University Yangsan Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05544825.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing